LinkedIn
Contact
Eng
De
Celldot
We are bringing advanced stem cell based therapies to the people
About Us
Celldot follows a step-by-step business strategy to make stem cell therapies more accessible and affordable by following means:

Partnership
Partnership with the leading research institutions and medical centres in the field of personalised healthcare.
Research
Access to the most advanced biotechnological research registered IP and state-of-the-art facilities for conducting joint research and application of advanced medical treatment protocols.
Infrastructure
Use of sophisticated biotechnological infrastructure for setting up R&D clusters for dedicated research
Advanced therapies
Development and commercialisation of advanced therapies based on stem cells application including reproductive medicine
Production and storage
Pluripotent stem cell production and banking
Promotion
Promoting the world-renowned centres of excellence in cell therapy services
The company uses the most advanced biotechnologies to provide their clients with an opportunity to preserve their biological materials, to conduct their comprehensive studies, including full genetic sequences, create their individualised pluripotent stem cells suitable for cell therapy.

The company is also promoting the best international partners and the most respected medical institutions that allow our clients to offer full-scale examination, clinical trials and application of advanced cell therapy methods and long-term follow-up.
Vision and Mission
Our vision is to become a top global company for personalized iPSC application.

Our mission is to deliver clinical grade products for application to offer treatment options for so far non-treatable diseases.
Core values
Everyday we work hard to make life of our clients better and happier
Respect
Respect for human life end ethical values
Responsibility
Promotion of social welfare
Innovation
Creative innovation
Services
Stem cell administration
Collection, diagnosis, cultivation of somatic stem cells and production of individual lines of induced pluripotent stem cells (iPSC) for further preservation and/or differentiation into cells for future therapy.
Stem cell banking
Banking of personal lines of pluripotent stem cells.
Conservation fully characterized autologous iPS cell lines.
EU representation of Hemafund family cord blood bank and cord blood banking networks.
Cell Therapy
EU representation of QR Health Solutions and other personalised medicine institutions.
Referral Service
Patient Advocacy and Referral Service for Advanced Medical Treatment Centers
Research
Our main goal is to provide resource for cell based, patient tailored therapies
We are using the potential of personalized cell therapies to generate new products for:

•Clinical application of iPSCs
•Disease modelling
•iPSC-based drug discovery and toxicity assessment

Meet our Partners
Our Team
Yaroslav Issakov
Founder and Shareholder
  • Founder group of biotech companies HEMAFUND
  • Navy service, Captain commander
  • Government services, Ukraine
  • IMF and World Bank Institute
  • European Bank for Reconstruction and Development (EBRD)
  • MBA Cass Business School
  • Chain entrepreneur
Benjamin Kurtze
Chief Executive Officer
  • M.Sc in Biochemistry at the Free University of Berlin
  • Research Scientist at the Einstein Center for Regenerative Therapies in the field of stem cell research
  • Postgraduate professional development as a Medical Science Liaison Manager

Kateryna Isakova
Commercial Director
  • Graduated from Medical University and European University of finance, management and business
  • Worked for an international pharmaceutical company and major wholesale pharmaceutical company where she headed the department of tenders
Oksana Rybachuk, PhD
Scientific Officer
  • PhD in human and animal physiology, Institute of Physiology, Ukraine
  • Research Scientist of Cell and Tissue Cultures Laboratory, State Institute of Genetic and Regenerative Medicine of Ukrainian National Academy of Medical Sciences, Ukraine
  • President's of Ukraine grant for young scientists, State Fund for Fundamental Research of Ukraine (SFFR)
Advisory Board
Dr Valeriy Zukin
  • CEO of Clinic of Reproductive Medicine Nadiya, one of the largest IVF clinics in Ukraine
  • Vice President of Ukrainian Association of Reproductive Medicine
  • Head of the Board of Directors of Maternity Hospital “Leleka"
  • PHD, Executive MBA
Our Contacts
Feel free to write and call us. We really love to communicate with our clients.
+49 160 92403666
office@celldot.tech
Kantstraße 105
10627 Berlin
Germany
LinkedIn
Kantstraße 105, 10627 Berlin, Germany
email: office@celldot.tech

CellDot GmbH

Geschäftsführer / CEO: Benjamin Kurtze
HRB 215098 B
Steuernummer / tax Number: 27/250/50411
Umsatzsteuer-ID: DE345492818
Berliner Volksbank IBAN: DE51100900002805469008
BIC: BEVODEB8
Established: November 29, 2019
Made on
Tilda